Sunflower Ginsenoside PLF is developed based on the Molecular Medicine. Ginseng, a famous Chinese medicine, is used as the initial raw material to make hydrolyzed ginsenosides by extraction, chromatography, purification, separation, targeted enzyme transformation and compatibility. The hydrolyzed ginsenosides contain sixteen kinds of ginsenosides, where ten of them are highly active rare ginsenosides which do not exist in natural cultivated ginseng but only exist in wild ginseng with small amount, such as F2、S-Rg2、R-Rg2、S-Rh1、R-Rh1、Rg4、Rk3、Rh4、S-Rg3、R-Rg3. The combination of these ten kinds of ginsenosides can synergistically promote the efficacy, which is more than 20 times higher than the natural ginsenosides according to the scientific ratio. Furthermore, combing the rest of six kinds of ginsenosides such as Rg1、Re、Rc、Rb2、Rb3、Rd, Sunflower Ginsenoside PLF contains more than 4% total ginsenosides and more than 0.2% rare ginsenoside F2 as the signature ingredient, which is the same content as 500 to 10,000 times of wild ginseng extraction. The product quality is in strict accordance with the high standard of Sunflower Group pharmaceutical using fingerprint and nuclear magnetic spectrum technology to achieve molecular stability, batch stability and efficacy stability. The product not only has high safety, but also has outstanding efficacy of anti-hair loss. The product efficacy is much higher than similar products in the market, even higher than the hair growth drug finasteride. Through the main mechanism of seborrheic alopecia research, the core channel is WNT signaling pathway. The efficacy validation of each target on the WNT pathway and mice experiment confirm that Sunflower Ginsenoside PLF has remarkable effects on hair area, density, length and hair follicle tissue which is more significant than finasteride.